Cohance Lifesciences Limited has informed the Exchange about Schedule of meet
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences (formerly Suven Pharmaceuticals) has scheduled a conference call for investors and analysts on Wednesday, August 13, 2025 at 6:15 PM IST. The call will discuss the company's unaudited financial results for Q1FY26, which are slated for the same day. Senior management including Executive Chairman Vivek Sharma, MD Dr. V Prasada Raju, CEO Dr. Sudhir Kumar Singh, CFO Himanshu Agarwal, and Head of IR Cyndrella Carvalho will attend. Dial-in numbers are provided for participants in India, Singapore, Hong Kong, USA, and UK, with pre-registration available for seamless access.
This is a routine investor engagement notice ahead of Q1FY26 earnings, with no new financial data disclosed. Shareholders should watch the August 13 results and management commentary for any updates on business performance and outlook, which could influence short-term stock sentiment.